GLP1R and type 2 diabetes mellitus: Recently, promising evidence has emerged supporting the effectiveness of integrated strategies for the treatment for T2D, combining innovative pharmacological approaches, such as GLP-1 receptor agonists like semaglutide, with non-pharmacological interventions, including regular physical activity.